1. Home
  2. TOP vs CTSO Comparison

TOP vs CTSO Comparison

Compare TOP & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TOP Financial Group Limited

TOP

TOP Financial Group Limited

HOLD

Current Price

$0.75

Market Cap

36.3M

Sector

Finance

ML Signal

HOLD

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

HOLD

Current Price

$0.61

Market Cap

38.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TOP
CTSO
Founded
2015
1997
Country
Singapore
United States
Employees
N/A
129
Industry
Investment Bankers/Brokers/Service
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.3M
38.2M
IPO Year
2021
2008

Fundamental Metrics

Financial Performance
Metric
TOP
CTSO
Price
$0.75
$0.61
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$5.38
AVG Volume (30 Days)
1.8M
109.7K
Earning Date
01-20-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
65.79
EPS
N/A
N/A
Revenue
N/A
$22,503,908.00
Revenue This Year
N/A
$12.21
Revenue Next Year
N/A
$20.37
P/E Ratio
N/A
N/A
Revenue Growth
N/A
48.53
52 Week Low
$0.61
$0.50
52 Week High
$3.33
$1.39

Technical Indicators

Market Signals
Indicator
TOP
CTSO
Relative Strength Index (RSI) 42.10 45.08
Support Level $0.61 $0.50
Resistance Level $1.11 $0.74
Average True Range (ATR) 0.11 0.06
MACD 0.00 0.00
Stochastic Oscillator 43.15 45.57

Price Performance

Historical Comparison
TOP
CTSO

About TOP TOP Financial Group Limited

TOP Financial Group Ltd is an online brokerage firm in Hong Kong specializing in trading local and overseas equities, futures, and options products. The Company generates brokerage commission income by enabling its customers to trade on multiple exchanges present globally. The company operates in only one segment which is the futures brokerage service.

About CTSO Cytosorbents Corporation

CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.

Share on Social Networks: